Literature DB >> 2444889

Different rhinovirus serotypes neutralized by antipeptide antibodies.

J McCray1, G Werner.   

Abstract

Recently, Rossman et al. have described the three-dimensional structure of a human rhinovirus. A possible host cell surface receptor binding site was identified with a cleft on each icosahedral face. Two highly conserved amino-acid sequences found in rhino-, polio-, and foot-and-mouth disease (FMD) viruses are located near the base of this site and could be important in maintaining its topology. We have prepared site-specific antibodies to two synthetic peptides which include these sequences. The antibodies bind to the predicted capsid proteins of rhinovirus and neutralize approximately 60% of 48 rhinovirus serotypes tested. These results could provide a route to a rhinovirus vaccine effective against most of the numerous serotypes of this virus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2444889     DOI: 10.1038/329736a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  9 in total

1.  Vaccine strategies to induce broadly protective immunity to rhinoviruses.

Authors:  Gary R McLean
Journal:  Hum Vaccin Immunother       Date:  2019-09-20       Impact factor: 3.452

2.  Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies.

Authors:  Katarzyna Niespodziana; Clarissa R Cabauatan; Petra Pazderova; Phyllis C Vacal; Judith Wortmann; Walter Keller; Peter Errhalt; Rudolf Valenta
Journal:  Int J Mol Sci       Date:  2022-05-04       Impact factor: 6.208

3.  An antibody- and synthetic peptide-defined rubella virus E1 glycoprotein neutralization domain.

Authors:  J S Wolinsky; E Sukholutsky; W T Moore; A Lovett; M McCarthy; B Adame
Journal:  J Virol       Date:  1993-02       Impact factor: 5.103

4.  Developing a vaccine for human rhinoviruses.

Authors:  Gary R McLean
Journal:  J Vaccines Immun       Date:  2014-10-01

Review 5.  Polyvalent vaccines: High-maintenance heroes.

Authors:  Barbara Schlingmann; Katelyn R Castiglia; Christopher C Stobart; Martin L Moore
Journal:  PLoS Pathog       Date:  2018-04-05       Impact factor: 6.823

6.  ELISA-Based Assay for Studying Major and Minor Group Rhinovirus-Receptor Interactions.

Authors:  Petra Pazderova; Eva E Waltl; Verena Niederberger-Leppin; Sabine Flicker; Rudolf Valenta; Katarzyna Niespodziana
Journal:  Vaccines (Basel)       Date:  2020-06-18

7.  PreDicta chip-based high resolution diagnosis of rhinovirus-induced wheeze.

Authors:  Katarzyna Niespodziana; Katarina Stenberg-Hammar; Spyridon Megremis; Clarissa R Cabauatan; Kamila Napora-Wijata; Phyllis C Vacal; Daniela Gallerano; Christian Lupinek; Daniel Ebner; Thomas Schlederer; Christian Harwanegg; Cilla Söderhäll; Marianne van Hage; Gunilla Hedlin; Nikolaos G Papadopoulos; Rudolf Valenta
Journal:  Nat Commun       Date:  2018-06-18       Impact factor: 14.919

8.  Rapid multiserotype detection of human rhinoviruses on optically coated silicon surfaces.

Authors:  R Ostroff; A Ettinger; H La; M Rihanek; L Zalman; J Meador; A K Patick; S Worland; B Polisky
Journal:  J Clin Virol       Date:  2001-05       Impact factor: 3.168

Review 9.  Understanding Rhinovirus Circulation and Impact on Illness.

Authors:  Camille Esneau; Alexandra Cate Duff; Nathan W Bartlett
Journal:  Viruses       Date:  2022-01-13       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.